vimarsana.com
Home
Live Updates
A bitter battle over the orphan drug program leaves patients pocketbooks at risk • Missouri Independent : vimarsana.com
A bitter battle over the 'orphan drug' program leaves patients' pocketbooks at risk • Missouri Independent
The FDA stopped reviewing applications for certain drugs or handing out exclusivity, agency spokesperson April Grant said.
Related Keywords
Minnesota ,
United States ,
Richard Burr ,
George Obrien ,
Mary Carmichael ,
Rachel Sher ,
Mayer Brown ,
Bernie Sanders ,
David Schull ,
Ketanji Brown Jackson ,
Us Circuit Court ,
House Energy ,
Us Supreme Court ,
Novartis ,
National Organization For Rare Disorders ,
Catalyst Pharmaceuticals Inc ,
Commerce Committee ,
Lore Wilkinson ,
April Grant ,
Catalyst Pharmaceutical Firdapse ,
Jacobus Pharmaceutical ,
Catalyst Pharmaceuticals ,
Orphan Drug Act ,
Orphan Drug ,
National Organization ,
Rare Disorders ,
Capitol Hill ,
vimarsana.com © 2020. All Rights Reserved.